ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Growth hormone axis

Growth hormone axis
Differentiated pituitary GH production, determined largely by POU1F1, is induced by GHRH and ghrelin and is suppressed by somatostatin by means of signaling through cognate somatotroph surface receptors. GH binds the preformed GHR dimer. Internal dimer rotation results in JAK2 phosphorylation (P) and signaling by JAK2-dependent and JAK2-independent pathways. GH targets include IGF-1, cell-proliferation factors, glucose metabolism, and cytoskeletal proteins. GHR internalization and translocation may directly induce nuclear proliferation genes[1]. GHR signaling may be abrogated by suppressors of cytokine-signaling proteins and by phosphatases. GH production may be suppressed by a range of conditions[2]. GH action targets pleiotropic tissues mainly in the organs depicted. A model of GH bound to the GHR dimer is shown.
GH: growth hormone; CNS: central nervous system; GHRH: GH-releasing hormone; POU1F1: POU domain class 1 transcription factor 1; IGF-1: insulin-like growth factor 1; GHR: GH receptor; JAK2: Janus kinase 2; P: phosphorylation; STAT: signal transducer and activator of transcription proteins; IRS: insulin receptor substrate.
From: Melmed S. Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med 2019; 380:2551. Copyright © 2019 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.

References:
  1. Waters MJ, Conway-Campbell BL. The oncogenic potential of autocrine human growth hormone in breast cancer. Proc Natl Acad Sci U S A 2004; 101:14992.
  2. Melmed S. Idiopathic adult growth hormone deficiency. J Clin Endocrinol Metab 2013; 98:2187.
Graphic 131558 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟